1. 1. Golovkin B.N. Metilsalitsilat (methylsalicylate; methyl-2-hydroxybenzoate). Biologicheski aktivnye veshchestva rastitelnogo proiskhozhdeniia [Methyl salicylate (methylsalicylate; methyl-2-hydroxybenzoate). Biologically active substances of plant origin]. Moscow: Nauka, 2001: 418-421. (In Russ.)
2. 2. Zdravookhranenie v Rossii [Healthcare in Russia] 2021: Stat. collection/Rosstat; Moscow, 2021. (In Russ.)
3. 3. Nasonov E. L., Galushko E. A., Alekberova Z. S. Revmatologiia. Rossiiskie klinicheskie rekomendatsii [Rheumatology. Russian clinical guidelines.]. Moscow: GEOTAR-Media, 2020. (In Russ.)
4. 4. Naumov A. V., Vertkin A. L. Lekarstvennyi formuliar komorbidnogo patsienta. Chast 1 Osteoartroz [Medication form for a comorbid patient. Part 1 Osteoarthritis]. Ambulatornyi priem [Outpatient Appointment]. 2015; 1 (1): 55-58. (In Russ.)
5. 5. Pilipovich A. A. Osteoartroz: patogeneticheskie i terapevticheskie aspekty [Osteoarthrosis: pathogenetic and therapeutic aspects]. RMZh [RMJ]. 2016; 7: 464-468. (In Russ.)